Close
4

Athena Athena

X

Find Levetiracetam manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
66
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES
left grey arrow
right gray arrow
  • TABLET;ORAL - 1GM
  • TABLET;ORAL - 250MG
  • TABLET;ORAL - 500MG
  • TABLET;ORAL - 750MG
  • INJECTABLE;INTRAVENOUS - 500MG/5ML (100MG/ML)
  • TABLET, EXTENDED RELEASE;ORAL - 500MG
  • TABLET, EXTENDED RELEASE;ORAL - 750MG

Looking for 102767-28-2 / Levetiracetam API manufacturers, exporters & distributors?

Levetiracetam manufacturers, exporters & distributors 1

77

PharmaCompass offers a list of Levetiracetam API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Levetiracetam manufacturer or Levetiracetam supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Levetiracetam manufacturer or Levetiracetam supplier.

PharmaCompass also assists you with knowing the Levetiracetam API Price utilized in the formulation of products. Levetiracetam API Price is not always fixed or binding as the Levetiracetam Price is obtained through a variety of data sources. The Levetiracetam Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Levetiracetam

Synonyms

102767-28-2, Keppra, (s)-2-(2-oxopyrrolidin-1-yl)butanamide, Keppra xr, (2s)-2-(2-oxopyrrolidin-1-yl)butanamide, Ucb l059

Cas Number

102767-28-2

Unique Ingredient Identifier (UNII)

44YRR34555

About Levetiracetam

A pyrrolidinone and acetamide derivative that is used primarily for the treatment of SEIZURES and some movement disorders, and as a nootropic agent.

AM20070676 Manufacturers

A AM20070676 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AM20070676, including repackagers and relabelers. The FDA regulates AM20070676 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AM20070676 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of AM20070676 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

AM20070676 Suppliers

A AM20070676 supplier is an individual or a company that provides AM20070676 active pharmaceutical ingredient (API) or AM20070676 finished formulations upon request. The AM20070676 suppliers may include AM20070676 API manufacturers, exporters, distributors and traders.

click here to find a list of AM20070676 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

AM20070676 USDMF

A AM20070676 DMF (Drug Master File) is a document detailing the whole manufacturing process of AM20070676 active pharmaceutical ingredient (API) in detail. Different forms of AM20070676 DMFs exist exist since differing nations have different regulations, such as AM20070676 USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A AM20070676 DMF submitted to regulatory agencies in the US is known as a USDMF. AM20070676 USDMF includes data on AM20070676's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The AM20070676 USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of AM20070676 suppliers with USDMF on PharmaCompass.

AM20070676 JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The AM20070676 Drug Master File in Japan (AM20070676 JDMF) empowers AM20070676 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the AM20070676 JDMF during the approval evaluation for pharmaceutical products. At the time of AM20070676 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of AM20070676 suppliers with JDMF on PharmaCompass.

AM20070676 KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a AM20070676 Drug Master File in Korea (AM20070676 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of AM20070676. The MFDS reviews the AM20070676 KDMF as part of the drug registration process and uses the information provided in the AM20070676 KDMF to evaluate the safety and efficacy of the drug.

After submitting a AM20070676 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their AM20070676 API can apply through the Korea Drug Master File (KDMF).

click here to find a list of AM20070676 suppliers with KDMF on PharmaCompass.

AM20070676 CEP

A AM20070676 CEP of the European Pharmacopoeia monograph is often referred to as a AM20070676 Certificate of Suitability (COS). The purpose of a AM20070676 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of AM20070676 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of AM20070676 to their clients by showing that a AM20070676 CEP has been issued for it. The manufacturer submits a AM20070676 CEP (COS) as part of the market authorization procedure, and it takes on the role of a AM20070676 CEP holder for the record. Additionally, the data presented in the AM20070676 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the AM20070676 DMF.

A AM20070676 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. AM20070676 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of AM20070676 suppliers with CEP (COS) on PharmaCompass.

AM20070676 WC

A AM20070676 written confirmation (AM20070676 WC) is an official document issued by a regulatory agency to a AM20070676 manufacturer, verifying that the manufacturing facility of a AM20070676 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting AM20070676 APIs or AM20070676 finished pharmaceutical products to another nation, regulatory agencies frequently require a AM20070676 WC (written confirmation) as part of the regulatory process.

click here to find a list of AM20070676 suppliers with Written Confirmation (WC) on PharmaCompass.

AM20070676 NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing AM20070676 as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for AM20070676 API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture AM20070676 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain AM20070676 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a AM20070676 NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of AM20070676 suppliers with NDC on PharmaCompass.

AM20070676 GMP

AM20070676 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of AM20070676 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right AM20070676 GMP manufacturer or AM20070676 GMP API supplier for your needs.

AM20070676 CoA

A AM20070676 CoA (Certificate of Analysis) is a formal document that attests to AM20070676's compliance with AM20070676 specifications and serves as a tool for batch-level quality control.

AM20070676 CoA mostly includes findings from lab analyses of a specific batch. For each AM20070676 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

AM20070676 may be tested according to a variety of international standards, such as European Pharmacopoeia (AM20070676 EP), AM20070676 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (AM20070676 USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY